HCV NS3 protease inhibitors
US8216999B2 · kind B2 · utility
18Cited by
6References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 1, 2008 |
| Grant date | Jul 10, 2012 |
| Priority date | — |
| Expiry date | Jan 21, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.